A Study of Anterior Approach Combined With Infrahepatic Inferior Vena Cava Clamping (AA+IVC)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Anterior approach results in better operative and survival outcomes compared with the conventional approach in patients with large hepatocellular carcinoma (HCC), and the liver hanging maneuver (LHM) is commonly applied to right hepatectomies as an adjunct to the anterior approach. It has several advantages, including better control of bleeding, protection of the inferior vena cava, exposure during deeper parenchymal dissection, rapid transaction, and guidelines for the direction of transection, but the LHM is considered technically difficult and precarious by some surgeons because of the retrohepatic dissection, and it is still limited by several factors. The technique is absolutely contraindicated in tumors infiltrating the IVC, and anterior approach still has the problem of bleeding from the hepatic vein.
Our previous study showed that infrahepatic inferior vena cava (IVC) clamping can reduce blood loss during conventional hepatic resection. The investigators guess infrahepatic IVC clamping may also reduce blood loss in anterior approach right hepatic resection. So the investigators conduct this prospective, randomized, controlled trial to compare anterior approach combined with infrahepatic IVC clamping and anterior approach in conjunction with the LHM.
| Condition | Intervention |
|---|---|
|
Anterior Approach Liver Resection Blood Loss External Causes of Morbidity and Mortality |
Procedure: infrahepatic IVC clamping Procedure: liver hanging maneuver |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Anterior Approach Combined With Infrahepatic Inferior Vena Cava Clamping Right Hepatic Resection:A Prospective Randomized Controlled Study |
- intraoperative total blood loss [ Time Frame: participants will be followed for the duration of the entire operation,an expected average of 140 minutes ] [ Designated as safety issue: Yes ]
- operation time [ Time Frame: the duration of the entire operation,an expected average of 140 minutes ] [ Designated as safety issue: Yes ]
- intraoperative CVP value [ Time Frame: participants will be followed for the duration of the parenchymal transection,an expected average of 20 minutes ] [ Designated as safety issue: Yes ]
- morbidity and mortality [ Time Frame: participants will be followed for the duration of the postoperative hospital stay,an expected average of 15 days ] [ Designated as safety issue: Yes ]
- postoperative hepatorenal function [ Time Frame: postoperative day 1,3 and 7 ] [ Designated as safety issue: Yes ]
- postoperative hospital stay [ Time Frame: the duration of the postoperative hospital stay,an expected average of 15 days ] [ Designated as safety issue: Yes ]
- disease-free survival duration and overall survival duration [ Time Frame: the duration from operation to recurrence or death,an expected average of 3 years ] [ Designated as safety issue: Yes ]
- blood loss during parenchymal transection [ Time Frame: the duration of the parenchymal transection,an expected average of 20 minutes ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 100 |
| Study Start Date: | May 2012 |
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | May 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| AA+IVC Clamping |
Procedure: infrahepatic IVC clamping
anterior approach combined with infrahepatic IVC clamping in right liver resection.
Other Name: group Ⅰ
|
| AA+LHM |
Procedure: liver hanging maneuver
anterior approach in conjunction with the LHM in right liver resection.
Other Name: group Ⅱ
|
Eligibility| Ages Eligible for Study: | 17 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Understanding and being willing to sign the informed consent form
- Aged 18-75 years
- Diagnosed hepatic masses by clinical findings and radiography,tumor size ≥ 5cm and located in the right lobe, need to perform right hemihepatectomy or major right hepatic resection (three Couinaud's segments)
- Without any surgery contraindication
- Child-Pugh grade A
Exclusion Criteria:
- Refusal to take part in the study
- With lymph node or extrahepatic metastases
- History of previous hepatectomy or other abdominal operation
- Those who can not be follow-up
Contacts and Locations| Study Director: | Jiamei Yang, MD | Eastern Hepatobiliary Surgery Hospital |
| Principal Investigator: | Chengjun Sui, MD | Eastern Hepatobiliary Surgery Hospital |
More Information
No publications provided
| Responsible Party: | Chengjun Sui,MD, Clinical Professor, Eastern Hepatobiliary Surgery Hospital |
| ClinicalTrials.gov Identifier: | NCT01608386 History of Changes |
| Other Study ID Numbers: | EHBHKY2012-002-16 |
| Study First Received: | May 22, 2012 |
| Last Updated: | May 26, 2012 |
| Health Authority: | China: Ministry of Health |
Keywords provided by Eastern Hepatobiliary Surgery Hospital:
|
Anterior approach liver hanging maneuver infrahepatic inferior vena cava clamping hepatic resection |
Additional relevant MeSH terms:
|
Hemorrhage Pathologic Processes |
ClinicalTrials.gov processed this record on May 21, 2013